0001179110-11-009087.txt : 20110601 0001179110-11-009087.hdr.sgml : 20110601 20110601190017 ACCESSION NUMBER: 0001179110-11-009087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110527 FILED AS OF DATE: 20110601 DATE AS OF CHANGE: 20110601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brinkley David L CENTRAL INDEX KEY: 0001302445 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 11886646 MAIL ADDRESS: STREET 1: 901 GATEWAY BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 edgar.xml FORM 4 - X0303 4 2011-05-27 0 0001080014 THERAVANCE INC THRX 0001302445 Brinkley David L THERAVANCE, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Head of Business Dev. Common Stock 2011-05-27 4 M 0 2652 3.10 A 99148 D Common Stock 2011-05-27 4 M 0 2789 3.10 A 101937 D Common Stock 2011-05-27 4 M 0 52371 9.69 A 154308 D Common Stock 2011-05-27 4 S 0 57812 25.31 D 96496 D Common Stock 2011-05-31 4 M 0 44402 9.69 A 140898 D Common Stock 2011-05-31 4 M 0 1039 18.37 A 141937 D Common Stock 2011-05-31 4 S 0 51500 25.65 D 90437 D Stock Option (Right to Buy) 3.10 2011-05-27 4 M 0 2652 0 D 2013-01-24 Common Stock 2652 0 D Stock Option (Right to Buy) 3.10 2011-05-27 4 M 0 2789 0 D 2013-01-24 Common Stock 2789 0 D Stock Option (Right to Buy 9.69 2011-05-27 4 M 0 52371 0 D 2014-03-29 Common Stock 52371 44402 D Stock Option (Right to Buy) 9.69 2011-05-31 4 M 0 44402 0 D 2014-03-29 Common Stock 44402 0 D Stock Option (Right to Buy) 18.37 2011-05-31 4 M 0 1039 0 D 2015-02-09 Common Stock 1039 15090 D This transaction was executed in multiple trades at prices ranging from $25.22 to $25.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $25.26 to $26.17. The price reported above reflects the weighted average sale price. Immediately exercisable Dispositions made pursuant to a plan intended to comply with Rule 10b5-1(c). David Brinkley 2011-06-01